The Role of Candidate Pharmacogenetic Variants in Determining Valproic Acid Efficacy, Toxicity, and Concentrations in Patients with Epilepsy

    October 2024 in “ Frontiers in Pharmacology
    Hady Yazbeck, Joe Youssef, Wassim Nasreddine, Abdallah Kurdi, Nathalie K. Zgheib, Ahmad Beydoun
    New to Valproic acid? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that in patients with genetic generalized epilepsies, certain gene variants were linked to differences in valproic acid treatment outcomes, including a higher likelihood of treatment failure, varying serum drug concentrations, and specific side effects like weight gain and hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results